Swedish VC firm BackingMinds has received around €20 million from the European Investment Fund (EIF) for BackingMinds Invest III in order to seek out promising entrepreneurs and businesses often overlooked…
Startup
-
-
Most founders switch on Google Ads in their first month because every launch checklist says to. Three months later, the dashboard shows sales, the bank account shows less than it…
-
Cellbox Solutions, a German warm-chain logistics technology company, has completed the final closing of its Series A financing, bringing the total to €5 million – the company will develop its…
-
Startup
Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials
Basel-based Nouscom, a clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135 million) Series D financing to fund the advancement of…
-
Startup
Turbine Capital closes €54 million DeepTech fund to connect Nordic startups with industrial leaders
Turbine Capital, a Swedish VC fund focused on early-stage DeepTech companies in the Nordics, announced the final close of its first fund at €54 million (SEK 608 million) and a…
-
Barcelona- and Madrid-based venture capital firm Enzo Ventures has announced the launch of Enzo Ventures II, a new €20 million fund aimed at backing technology startups founded by entrepreneurs from…
-
Startup
AWS wants to prove its cloud can survive without the US, European startups are already there
Amazon Web Services (AWS) is preparing to test whether its European Sovereign Cloud can operate independently of foreign infrastructure – challenging if Europe can maintain greater control over its digital…
-
Microbiotica, a British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines, today announces the first close of a €42 million (£36 million) Series C financing. The financing…
-
Startup
Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients
OMass Therapeutics, a UK BioTech company developing small molecule therapeutics against highly validated target ecosystems, announced an oversubscribed €275 million (£230 million) Series C round. The round was co-led by…
-
NVIDIA has had a busy week on this side of the pond. From announcing new investments in British and French startups to launching collaborations in Sweden, supporting AI research and…
